Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2866 AL 2880

Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy

Sarangi SC, Sopory P, Reeta KH.

Neurol India. 2021 Mar-Apr;69(2):252-259. doi: 10.4103/0028-3886.314522.

Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders

Chalkias IN, Tegos T, Topouzis F, Tsolaki M.

Eur J Ophthalmol. 2021 Nov;31(6):2808-2817. doi: 10.1177/11206721211016311. Epub 2021 May 17.

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis

Paolini Paoletti F, Simoni S, Parnetti L, Gaetani L.

Int J Mol Sci. 2021 May 7;22(9):4958. doi: 10.3390/ijms22094958.

Biomarkers for neurodegenerative diseases

Hansson O.

Nat Med. 2021 Jun;27(6):954-963. doi: 10.1038/s41591-021-01382-x. Epub 2021 Jun 3.

Multimodal retinal imaging to detect and understand Alzheimer's and Parkinson's disease

Moons L, De Groef L.

Curr Opin Neurobiol. 2022 Feb;72:1-7. doi: 10.1016/j.conb.2021.07.007. Epub 2021 Aug 14.

Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease

Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B; Parkinson’s Progression Markers Initiative.

PLoS One. 2021 Oct 7;16(10):e0257372. doi: 10.1371/journal.pone.0257372. eCollection 2021.

Ultrasensitive detection of blood biomarkers of Alzheimer's and Parkinson's diseases: a systematic review

Singh K, Cheung BM, Xu A.

Biomark Med. 2021 Dec;15(17):1693-1708. doi: 10.2217/bmm-2021-0219. Epub 2021 Nov 8.

Lewy Body Dementias: Controversies and Drug Development

Chiu SY, Bowers D, Armstrong MJ.

Neurotherapeutics. 2022 Jan;19(1):55-67. doi: 10.1007/s13311-021-01161-z. Epub 2021 Dec 2.

Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future

Karaboğa MNS, Sezgintürk MK.

J Pharm Biomed Anal. 2022 Feb 5;209:114479. doi: 10.1016/j.jpba.2021.114479. Epub 2021 Nov 24.

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease

Kim J.

Int J Mol Sci. 2021 Mar 13;22(6):2929. doi: 10.3390/ijms22062929.

Retinal imaging biomarkers of neurodegenerative diseases

Christinaki E, Kulenovic H, Hadoux X, Baldassini N, Van Eijgen J, De Groef L, Stalmans I, van Wijngaarden P.

Clin Exp Optom. 2022 Mar;105(2):194-204. doi: 10.1080/08164622.2021.1984179. Epub 2021 Nov 9.

Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study

Brosseron F, Kolbe CC, Santarelli F, Carvalho S, Antonell A, Castro-Gomez S, Tacik P, Namasivayam AA, Mangone G, Schneider R, Latz E, Wüllner U, Svenningsson P, Sánchez-Valle R, Molinuevo JL, Corvol JC, Heneka MT; AETIONOMY study group.

Alzheimers Dement. 2020 Feb;16(2):292-304. doi: 10.1016/j.jalz.2019.07.018. Epub 2020 Jan 6.

Systematic review of genetic association studies in people with Lewy body dementia

Sanghvi H, Singh R, Morrin H, Rajkumar AP.

Int J Geriatr Psychiatry. 2020 May;35(5):436-448. doi: 10.1002/gps.5260. Epub 2020 Jan 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias